Durvalumab as consolidation therapy in patients who received chemoradiotherapy for unresectable stage III NSCLC: Real-world data from an expanded access program in Brazil (LACOG 0120). - Zukin M; Gondim V; Shimada AK; Lima EMEA; Mathias C; Barra WF; William Junior WN; Padoan M; Bittencourt Y; Yamamura R; Silva CEB; Rossato LJ; et al. (Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, 2025)